Guideline for the treatment of Hansen's disease in Japan

Japanese Journal of Leprosy

Volumn 69, Issue 3, 2000, Pages 157-177

  Goto, M ^a   Ishida, Y ^a   Gidoh, M ^a   Nagao, E ^a   Namisato, M ^a   Ishii, N ^a   Ozaki, M ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Guideline; Japan; Leprosy; Maintenance therapy; Multi drug therapy

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; DAPSONE; LEPROSTATIC AGENT; LEVOFLOXACIN; MINOCYCLINE; OFLOXACIN; RIFAMPICIN; SPARFLOXACIN;

ARTICLE; CLINICAL PROTOCOL; DEFORMITY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; JAPAN; LEPROSY; MAINTENANCE THERAPY; MYCOBACTERIUM LEPRAE; PRACTICE GUIDELINE; WORLD HEALTH ORGANIZATION;

EID: 0034531816     PISSN: 13423681     EISSN: None     Source Type: Journal    
DOI: 10.5025/hansen.69.157     Document Type: Article

References (34)

1. Classification of leprosy according to immunity - A five group system
2. Chemotherapy of leprosy for control programmes
3. WHO expert committee on leprosy, sixth report
4. Chemotherapy of leprosy, Report of a WHO study group
5. WHO expert committee on leprosy, seventh report
6. Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method
7. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats
8. On characteristic antiinflammatory effects of several antileprosy drugs
9. Pharmcokinetics of clofazimine in healthy volunteers
10. Clofazimine binding studies with deoxyribonucleic acid
11. Treatment of moderately severe erythema nodosum leprosum with clofazimine-a controlled trial
12. Phase I study of levofloxacin, (s) - (-) -ofloxacin
13. Minocycline in lepromatous leprosy
14. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen
15. Relapse following various types of multidrug therapy in multibacillary leprosy
16. The smear